If you are transitioning into clinical data programming or pharmaceutical statistical analysis, understanding the CDISC standards is essential. The two primary data standards you will work with every day are SDTM and ADaM.

🔬 Clinical SAS Career Prep: Master CDISC standards, SDTM domain creation, and ADaM dataset building in our flagship Clinical SAS Programming & CDISC Masterclass.

What is SDTM (Study Data Tabulation Model)?

SDTM is the standard format for representing clinical trial raw data collected on Case Report Forms (CRFs) and electronic data capture (EDC) systems. SDTM is observation-level and standardized across all sponsors.

  • DM: Demographics (one record per subject)
  • AE: Adverse Events (one record per event occurrence)
  • VS: Vital Signs (one record per measurement per visit)
  • LB: Laboratory Tests

What is ADaM (Analysis Data Model)?

ADaM datasets are derived directly from SDTM. They are specifically structured to generate statistical Tables, Listings, and Figures (TLFs) for FDA and EMA regulatory submissions without complex transformations inside reporting procedures.

"SDTM captures what happened to the patient. ADaM structures the data so statisticians and programmers can analyze the clinical efficacy and safety."

Key Differences at a Glance

Feature           SDTM                            ADaM
----------------------------------------------------------------------
Purpose           Standardized raw data           Statistical analysis & TLFs
Target Audience   Data Managers & Reviewers       Biostatisticians & Regulators
Subject Dataset   DM                              ADSL (Subject-Level Analysis)
Event Dataset     AE                              ADAE (Analysis Adverse Events)
Derivations       Minimal (raw-aligned)           Heavy (baselines, flags, changes)

How ADSL Forms the Backbone of All Clinical Analyses

Every clinical project begins with ADSL (Subject-Level Analysis Dataset). ADSL contains critical analysis population flags such as SAFFL (Safety Population Flag) and ITTFL (Intent-to-Treat Flag), treatment start/end dates, and demographic baseline variables.